(thirdQuint)Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm X54 System.

 50 subjects with previously diagnosed Type 1 Diabetes Mellitus will be studied.

 The subject population includes the following subsets: 4 pediatric subjects aged 16 -17 years, 4 young adult subjects age 18-21 years, and 42 adult subjects age 22-60 years at time of enrollment.

 Results for all subjects will be analyzed.

.

 Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm X54 System@highlight

The purpose of this study is to assess the efficacy of the Low Glucose Suspend (LGS) feature in reducing hypoglycemia with the MiniMed Paradigm(R) X54 System with hypoglycemic induction from exercise.

 The study will consist of a total of 50 subjects, age 16 through 60 years with Type 1 Diabetes Mellitus.

